37.71
Schlusskurs vom Vortag:
$38.18
Offen:
$38.35
24-Stunden-Volumen:
471.01K
Relative Volume:
0.64
Marktkapitalisierung:
$2.19B
Einnahmen:
$32.87M
Nettoeinkommen (Verlust:
$674.31M
KGV:
3.3195
EPS:
11.36
Netto-Cashflow:
$-330.11M
1W Leistung:
-2.81%
1M Leistung:
-0.05%
6M Leistung:
+9.81%
1J Leistung:
-17.77%
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
Firmenname
Agios Pharmaceuticals Inc
Sektor
Branche
Telefon
617-649-8600
Adresse
88 SIDNEY STREET, CAMBRIDGE, MA
Vergleichen Sie AGIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AGIO
Agios Pharmaceuticals Inc
|
37.71 | 2.22B | 32.87M | 674.31M | -330.11M | 11.36 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-24 | Eingeleitet | H.C. Wainwright | Buy |
2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
2024-10-10 | Fortgesetzt | Raymond James | Outperform |
2024-09-27 | Herabstufung | Leerink Partners | Outperform → Market Perform |
2024-02-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-02-03 | Eingeleitet | Piper Sandler | Overweight |
2022-11-17 | Hochstufung | Goldman | Sell → Neutral |
2022-07-27 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2021-12-03 | Eingeleitet | BofA Securities | Buy |
2021-07-30 | Herabstufung | Goldman | Neutral → Sell |
2021-07-01 | Eingeleitet | Raymond James | Mkt Perform |
2021-06-10 | Eingeleitet | H.C. Wainwright | Buy |
2021-03-01 | Herabstufung | JP Morgan | Overweight → Neutral |
2021-03-01 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2021-02-26 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2020-10-22 | Hochstufung | Barclays | Equal Weight → Overweight |
2020-03-04 | Eingeleitet | Barclays | Equal Weight |
2019-11-26 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-09-23 | Hochstufung | Guggenheim | Neutral → Buy |
2019-05-23 | Fortgesetzt | Goldman | Neutral |
2019-02-15 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2018-09-25 | Eingeleitet | Leerink Partners | Mkt Perform |
2018-05-23 | Eingeleitet | Citigroup | Buy |
2018-04-11 | Bestätigt | Credit Suisse | Outperform |
2018-02-15 | Bestätigt | Needham | Buy |
2018-02-15 | Bestätigt | SunTrust | Buy |
2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
2017-08-10 | Bestätigt | Needham | Buy |
2017-08-08 | Bestätigt | SunTrust | Buy |
2017-08-02 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
2017-06-26 | Herabstufung | Janney | Buy → Neutral |
2017-01-17 | Hochstufung | Oppenheimer | Perform → Outperform |
2016-10-24 | Eingeleitet | Needham | Buy |
2016-06-13 | Hochstufung | JP Morgan | Neutral → Overweight |
2016-05-18 | Bestätigt | SunTrust | Buy |
Alle ansehen
Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten
What moving averages say about Agios Pharmaceuticals Inc.July 2025 Market Mood & Weekly Momentum Picks - Newser
What technical models suggest about Agios Pharmaceuticals Inc.’s comeback2025 Top Decliners & Community Verified Trade Alerts - Newser
Full technical analysis of Agios Pharmaceuticals Inc. stock2025 Technical Overview & Risk Controlled Swing Trade Alerts - Newser
Should you wait for a breakout in Agios Pharmaceuticals Inc.Short Setup & Fast Gain Stock Trading Tips - Newser
Has Agios Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Detailed Earnings Play Strategies - Newser
Can trapped investors hope for a rebound in Agios Pharmaceuticals IncWeekly Stock Summary & Technical Buy Zone Confirmations - Newser
Is Agios Pharmaceuticals Inc. stock poised for growth2025 Earnings Impact & Technical Analysis for Trade Confirmation - Newser
Price momentum metrics for Agios Pharmaceuticals Inc. explainedWeekly Investment Summary & Technical Pattern Based Signals - Newser
Exit strategy if you’re trapped in Agios Pharmaceuticals Inc.July 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser
Agios Pharmaceuticals Inc.’s volatility index tracking explainedCPI Data & Weekly Breakout Stock Alerts - Newser
Chart based exit strategy for Agios Pharmaceuticals Inc.Profit Target & Consistent Profit Alerts - Newser
Price action breakdown for Agios Pharmaceuticals Inc.July 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser
Published on: 2025-08-30 16:42:25 - Newser
Historical volatility pattern of Agios Pharmaceuticals Inc. visualized2025 Year in Review & High Accuracy Trade Alerts - Newser
Heatmap analysis for Agios Pharmaceuticals Inc. and competitorsJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser
Should you hold or exit Agios Pharmaceuticals Inc. nowMarket Activity Report & Low Risk Entry Point Guides - Newser
Does Agios Pharmaceuticals Inc. show high probability of rebound2025 Momentum Check & Smart Money Movement Tracker - Newser
How sentiment analysis helps forecast Agios Pharmaceuticals Inc.Quarterly Market Summary & Free Risk Controlled Daily Trade Plans - Newser
Will Agios Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Trends & AI Powered Buy and Sell Recommendations - Newser
Agios Pharmaceuticals Inc. stock trendline breakdownWeekly Trading Summary & Advanced Swing Trade Entry Alerts - Newser
Can trapped investors hope for a rebound in Agios Pharmaceuticals Inc.July 2025 Review & Consistent Income Trade Ideas - Newser
Automated trading signals detected on Agios Pharmaceuticals Inc.Portfolio Risk Summary & Low Drawdown Trading Techniques - Newser
Long term hold vs stop loss in Agios Pharmaceuticals Inc.Market Performance Summary & Weekly Setup with High ROI Potential - Newser
Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders - Yahoo Finance
Combining machine learning predictions for Agios Pharmaceuticals Inc.Gold Moves & Smart Swing Trading Techniques - Newser
Can a trend reversal in Agios Pharmaceuticals Inc. lead to recovery2025 Year in Review & Stepwise Trade Signal Guides - Newser
How to track smart money flows in Agios Pharmaceuticals Inc.2025 Retail Activity & Real-Time Volume Triggers - Newser
Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Agios Pharmaceuticals Inc-Aktie (AGIO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Scadden David | Director |
Aug 27 '25 |
Sale |
40.00 |
200 |
8,000 |
17,603 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):